Loss of anti‐spike antibodies following mRNA vaccination for COVID‐19 among patients with multiple myeloma

BACKGROUND: Multiple myeloma (MM) patients have variable responses to mRNA vaccination to COVID‐19. Little is known regarding their vaccine‐induced antibody levels over time. METHODS: We monitored spike IgG antibody levels over 24 weeks among a subset of 18 MM patients who showed a full response aft...

Descripción completa

Detalles Bibliográficos
Autores principales: Stampfer, Samuel D., Bujarski, Sean, Goldwater, Marissa‐Skye, Jew, Scott, Regidor, Bernard, Chen, Haiming, Xu, Ning, Li, Mingjie, Fung, Eddie, Swift, Regina, Beatty, Bethany, Eshaghian, Shahrooz, Berenson, James R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172160/
https://www.ncbi.nlm.nih.gov/pubmed/36891732
http://dx.doi.org/10.1002/cnr2.1803

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172160/
https://www.ncbi.nlm.nih.gov/pubmed/36891732
http://dx.doi.org/10.1002/cnr2.1803

Ejemplares similares